Brind.
  1. Amicus Therapeutics received drug approvals in multiple countries, including the US, Japan, Canada, and Switzerland.

Amicus Therapeutics received MHLW approval in Japan for Pombiliti + Opfolda treatment for LOPD.

1 report, 0 independent Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Amicus Therapeutics received MHLW approval in Japan for Pombiliti + Opfolda treatment for LOPD.

Who's involved

What this event is mainly about
Amicus TherapeuticsMinistry of Health

Keep exploring

Part of

Amicus Therapeutics received drug approvals in multiple countries, including the US, Japan, Canada, and Switzerland. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet